Please enable JavaScript to continue using this application.

Compare $COYA vs $UNCY | Chartloom

Compare

$COYA vs $UNCY

Coya Therapeutics Inc · Unicycive Therapeutics Inc

COYA

Coya Therapeutics Inc

UNCY

Unicycive Therapeutics Inc

Compare $COYA vs $UNCY

Comparing Coya Therapeutics Inc and Unicycive Therapeutics Inc

COYACoya Therapeutics Inc

UNCYUnicycive Therapeutics Inc

COYACoya Therapeutics Inc

Market cap

$116M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

35.49x

Rev growth (TTM)

1793.6%

YTD performance

-12.4%

52W performance

-21.6%

FCF yield

-15.3%

UNCYUnicycive Therapeutics Inc

Market cap

$110M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.31x

Rev growth (TTM)

—

YTD performance

-29.1%

52W performance

-13.8%

FCF yield

-25.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COYA

UNCY

Detailed metrics comparison

COYA

Coya Therapeutics Inc

UNCY

Unicycive Therapeutics Inc

Market Cap

COYA$116M

UNCY$110M

Enterprise Value

COYA$73M

UNCY$66M

Price

COYA$4.95

UNCY$4.11

P/E Ratio

COYAN/A

UNCYN/A

P/S Ratio

COYA14.48x

UNCY31.15x

EV/Sales

COYA9.10x

UNCY0.00x

EV/EBITDA

COYA0.00x

UNCY0.00x

P/B Ratio

COYA2.61x

UNCY2.21x

P/FCF Ratio

COYAN/A

UNCYN/A

EV/FCF

COYA-4.10x

UNCY-2.35x

PEG Ratio

COYAN/A

UNCYN/A

Forward P/E (NTM)

COYAN/A

UNCYN/A

Forward P/S (NTM)

COYA35.49x

UNCY0.31x

Revenue (TTM)

COYA$8M

UNCY$0

Revenue Growth (YoY)

COYA1793.6%

UNCYN/A

Forward Rev Growth

COYA389.9%

UNCY37378.0%

Gross Margin (TTM)

COYA0.0%

UNCY0.0%

Operating Margin (TTM)

COYA0.0%

UNCY0.0%

EBITDA Margin (TTM)

COYA-259.8%

UNCY0.0%

Net Margin (TTM)

COYA-270.2%

UNCY0.0%

FCF Margin (TTM)

COYA-221.6%

UNCYN/A

Net Income (TTM)

COYA$-22M

UNCY$-35M

FCF (TTM)

COYA$-18M

UNCY$-28M

EPS (TTM)

COYA-$0.92

UNCY-$1.31

ROE (TTM)

COYA-5332.0%

UNCY-8881.0%

ROA (TTM)

COYA-4748.0%

UNCY-5966.0%

ROIC (TTM)

COYA-5332.0%

UNCY-8881.0%

Cash

COYA$43M

UNCY$44M

Debt

COYA$0

UNCY$0

Net Cash/Debt

COYA$43M

UNCY$44M

Current Ratio (TTM)

COYA13.40x

UNCY3.81x

Quick Ratio (TTM)

COYA12.29x

UNCY3.28x

Debt/Equity (TTM)

COYA0.00x

UNCY0.00x

Debt/Assets (TTM)

COYA0.0%

UNCY0.0%

Interest Coverage (TTM)

COYAN/A

UNCYN/A

Net Debt/EBITDA (TTM)

COYA0.00x

UNCY0.00x

Beta

COYA0.58

UNCY1.78

52W Performance

COYA-21.6%

UNCY-13.8%

YTD Performance

COYA-12.4%

UNCY-29.1%

% from 52W High

COYA-36.1%

UNCY-53.0%

% from 52W Low

COYA33.4%

UNCY4.6%

Asset Turnover (TTM)

COYA0.18x

UNCY0.05x

FCF Yield (TTM)

COYA-15.3%

UNCY-25.4%

Earnings Yield (TTM)

COYA-18.7%

UNCY-32.1%

Dividend Yield (TTM)

COYAN/A

UNCYN/A

Rule of 40

COYA1,571.9

UNCY0.0

EV/GP/RG

COYAN/A

UNCYN/A

Ticker research

View COYA research View UNCY research

Metric	COYA Coya Therapeutics Inc	UNCY Unicycive Therapeutics Inc
Market & Valuation
Market Cap	$116M	$110M
Enterprise Value	$73M	$66M
Price	$4.95	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	14.48x	31.15x
EV/Sales	9.10x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.61x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.10x	-2.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	35.49x	0.31x
Revenue & Growth
Revenue (TTM)	$8M	$0
Revenue Growth (YoY)	1793.6%	N/A
Forward Rev Growth	389.9%	37378.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-259.8%	0.0%
Net Margin (TTM)	-270.2%	0.0%
FCF Margin (TTM)	-221.6%	N/A
Net Income (TTM)	$-22M	$-35M
FCF (TTM)	$-18M	$-28M
EPS (TTM)	-$0.92	-$1.31
ROE (TTM)	-5332.0%	-8881.0%
ROA (TTM)	-4748.0%	-5966.0%
ROIC (TTM)	-5332.0%	-8881.0%
Financial Health
Cash	$43M	$44M
Debt	$0	$0
Net Cash/Debt	$43M	$44M
Current Ratio (TTM)	13.40x	3.81x
Quick Ratio (TTM)	12.29x	3.28x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	1.78
52W Performance	-21.6%	-13.8%
YTD Performance	-12.4%	-29.1%
% from 52W High	-36.1%	-53.0%
% from 52W Low	33.4%	4.6%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.05x
FCF Yield (TTM)	-15.3%	-25.4%
Earnings Yield (TTM)	-18.7%	-32.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,571.9	0.0
EV/GP/RG	N/A	N/A
Ticker research	View COYA research	View UNCY research

Valuation

P/S Ratio

COYA

14.48x

UNCY

31.15x

EV/FCF

COYA

-4.10x

UNCY

-2.35x

Growth & revenue

Revenue Growth TTM

COYA

1793.6%

Forward Revenue Growth

UNCY

37378.0%

COYA

389.9%

Profitability & performance

Gross Margin

COYA

0.0%

UNCY

0.0%

ROE

COYA

-5332.0%

UNCY

-8881.0%

FCF Yield %

COYA

-15.3%

UNCY

-25.4%

52-Week Performance

UNCY

-13.8%

COYA

-21.6%

Detailed metrics comparison

COYA

Coya Therapeutics Inc

UNCY

Unicycive Therapeutics Inc

Market Cap

COYA$116M

UNCY$110M

Enterprise Value

COYA$73M

UNCY$66M

Price

COYA$4.95

UNCY$4.11

P/E Ratio

COYAN/A

UNCYN/A

P/S Ratio

COYA14.48x

UNCY31.15x

EV/Sales

COYA9.10x

UNCY0.00x

EV/EBITDA

COYA0.00x

UNCY0.00x

P/B Ratio

COYA2.61x

UNCY2.21x

P/FCF Ratio

COYAN/A

UNCYN/A

EV/FCF

COYA-4.10x

UNCY-2.35x

PEG Ratio

COYAN/A

UNCYN/A

Forward P/E (NTM)

COYAN/A

UNCYN/A

Forward P/S (NTM)

COYA35.49x

UNCY0.31x

Revenue (TTM)

COYA$8M

UNCY$0

Revenue Growth (YoY)

COYA1793.6%

UNCYN/A

Forward Rev Growth

COYA389.9%

UNCY37378.0%

Gross Margin (TTM)

COYA0.0%

UNCY0.0%

Operating Margin (TTM)

COYA0.0%

UNCY0.0%

EBITDA Margin (TTM)

COYA-259.8%

UNCY0.0%

Net Margin (TTM)

COYA-270.2%

UNCY0.0%

FCF Margin (TTM)

COYA-221.6%

UNCYN/A

Net Income (TTM)

COYA$-22M

UNCY$-35M

FCF (TTM)

COYA$-18M

UNCY$-28M

EPS (TTM)

COYA-$0.92

UNCY-$1.31

ROE (TTM)

COYA-5332.0%

UNCY-8881.0%

ROA (TTM)

COYA-4748.0%

UNCY-5966.0%

ROIC (TTM)

COYA-5332.0%

UNCY-8881.0%

Cash

COYA$43M

UNCY$44M

Debt

COYA$0

UNCY$0

Net Cash/Debt

COYA$43M

UNCY$44M

Current Ratio (TTM)

COYA13.40x

UNCY3.81x

Quick Ratio (TTM)

COYA12.29x

UNCY3.28x

Debt/Equity (TTM)

COYA0.00x

UNCY0.00x

Debt/Assets (TTM)

COYA0.0%

UNCY0.0%

Interest Coverage (TTM)

COYAN/A

UNCYN/A

Net Debt/EBITDA (TTM)

COYA0.00x

UNCY0.00x

Beta

COYA0.58

UNCY1.78

52W Performance

COYA-21.6%

UNCY-13.8%

YTD Performance

COYA-12.4%

UNCY-29.1%

% from 52W High

COYA-36.1%

UNCY-53.0%

% from 52W Low

COYA33.4%

UNCY4.6%

Asset Turnover (TTM)

COYA0.18x

UNCY0.05x

FCF Yield (TTM)

COYA-15.3%

UNCY-25.4%

Earnings Yield (TTM)

COYA-18.7%

UNCY-32.1%

Dividend Yield (TTM)

COYAN/A

UNCYN/A

Rule of 40

COYA1,571.9

UNCY0.0

EV/GP/RG

COYAN/A

UNCYN/A

Ticker research

View COYA research View UNCY research

Metric	COYA Coya Therapeutics Inc	UNCY Unicycive Therapeutics Inc
Market & Valuation
Market Cap	$116M	$110M
Enterprise Value	$73M	$66M
Price	$4.95	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	14.48x	31.15x
EV/Sales	9.10x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.61x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.10x	-2.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	35.49x	0.31x
Revenue & Growth
Revenue (TTM)	$8M	$0
Revenue Growth (YoY)	1793.6%	N/A
Forward Rev Growth	389.9%	37378.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-259.8%	0.0%
Net Margin (TTM)	-270.2%	0.0%
FCF Margin (TTM)	-221.6%	N/A
Net Income (TTM)	$-22M	$-35M
FCF (TTM)	$-18M	$-28M
EPS (TTM)	-$0.92	-$1.31
ROE (TTM)	-5332.0%	-8881.0%
ROA (TTM)	-4748.0%	-5966.0%
ROIC (TTM)	-5332.0%	-8881.0%
Financial Health
Cash	$43M	$44M
Debt	$0	$0
Net Cash/Debt	$43M	$44M
Current Ratio (TTM)	13.40x	3.81x
Quick Ratio (TTM)	12.29x	3.28x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	1.78
52W Performance	-21.6%	-13.8%
YTD Performance	-12.4%	-29.1%
% from 52W High	-36.1%	-53.0%
% from 52W Low	33.4%	4.6%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.05x
FCF Yield (TTM)	-15.3%	-25.4%
Earnings Yield (TTM)	-18.7%	-32.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,571.9	0.0
EV/GP/RG	N/A	N/A
Ticker research	View COYA research	View UNCY research